| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer, EVP | Chief Financial Officer
2 companies
Julia Aijun Wang is Chief Financial Officer, EVP at LH, with reported holdings spanning 2 companies. From July 2021 to February 2026, the filings on record show 0 open-market purchases and 11 sales. Julia Aijun Wang's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $643K at current prices.
Our model assigns Julia Aijun Wang a middling insider score of 54/100, based on 11 past trades. Over a 12-month horizon, 45.5% of those trades were profitable, with an average 12-month return of -16.8%.
Julia Aijun Wang's largest disclosed position is in LH as Chief Financial Officer, EVP, worth about $643K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2021 | ONC Beone Medicines Ltd. | Chief Financial Officer | Sell | 308 | $349.06 | $107,511.68 | -100% | +3.4% | -52.3% |